Clinical Outcomes Over 3-Year Cumulative Efanesoctocog Alfa Exposure Since Parent Study Baseline: Interim Analysis of XTEND-ed Long-Term Extension Study in Patients with Severe Hemophilia A
Clinical Outcomes Over 3-Year Cumulative Efanesoctocog Alfa Exposure Since Parent Study Baseline: Interim Analysis of XTEND-ed Long-Term Extension Study in Patients with Severe Hemophilia A. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926037295?dgcid=rss_sd_all
Clinical Outcomes Over 3-Year Cumulative Efanesoctocog Alfa Exposure Since Parent Study Baseline: Interim Analysis of XTEND-ed Long-Term Extension Study in Patients with Severe Hemophilia A. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926037295?dgcid=rss_sd_all
“Clinical Outcomes Over 3-Year Cumulative Efanesoctocog Alfa Exposure Since Parent Study Baseline: Interim Analysis of XTEND-ed Long-Term Extension Study in Patients with Severe Hemophilia A.” Research and Practice in Thrombosis and Haemostasis.
@article{article64060,
title = {Clinical Outcomes Over 3-Year Cumulative Efanesoctocog Alfa Exposure Since Parent Study Baseline: Interim Analysis of XTEND-ed Long-Term Extension Study in Patients with Severe Hemophilia A},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926037295?dgcid=rss_sd_all}
}